Ticker Scorecard - OGN Basics Company: Organon & Co.. IPO Date: May 14, 2021 Sector: Healthcare Industry: Drug Manufacturers - General Market Cap: $3.99B Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 1.51% Avg Daily Range (30 D): $0.27 | 1.71% Avg Daily Range (90 D): $0.25 | 1.57% Institutional Daily Volume Avg Daily Volume: 2.1M Avg Daily Volume (30 D): 2.45M Avg Daily Volume (90 D): 2.51M Trade Size Avg Trade Size (Sh.): 93 Avg Trade Size (Sh.) (30 D): 94 Avg Trade Size (Sh.) (90 D): 97 Institutional Trades Total Inst.Trades: 3,534 Avg Inst. Trade: $3.46M Avg Inst. Trade (30 D): $2.67M Avg Inst. Trade (90 D): $3.8M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $8.13M Avg Closing Trade (30 D): $5.07M Avg Closing Trade (90 D): $7.06M Avg Closing Volume: 352.07K     News Jan 1, 2025 @ 12:55 PM Want $2,000 in Annual Dividends? Invest $11,000 in... Source: David Jagielski Oct 28, 2024 @ 1:25 PM Organon Completes Acquisition of Dermavant, includ... Source: Globe Newswire Oct 3, 2024 @ 12:30 PM Sexual Wellness Market to Witness 4.7% CAGR by 203... Source: Globe Newswire Sep 18, 2024 @ 7:20 PM Roivant Sciences Offloads Psoriasis Medicine Maker... Source: Benzinga Editor Sep 18, 2024 @ 11:30 AM Organon to Acquire Dermavant including its Innovat... Source: Globe Newswire Financials   TTM Q3 2024 Q2 2024 Basic EPS $5.07 $1.39 $.76 Diluted EPS $5.04 $1.38 $.75 Revenue $ 6.41B $ 1.58B $ 1.61B Gross Profit $ 3.73B $ 923M $ 939M Net Income / Loss $ 1.3B $ 359M $ 195M Operating Income / Loss $ 782M $ 207M $ 235M Cost of Revenue $ 2.68B $ 659M $ 668M Net Cash Flow $ 349M $ 59M $ 129M PE Ratio 0.00